BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/24/2025 7:36:25 AM | Browse: 373 | Download: 580
Publication Name World Journal of Gastrointestinal Surgery
Manuscript ID 109700
Country China
ISSN 1948-9366 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Retrospective Study
Article Title Retrospective analysis of predictive factors for pathological complete response after neoadjuvant chemotherapy in gastric cancer
Manuscript Source Unsolicited Manuscript
All Author List Bo Bi, Chen Liu, Jie Chai and Yun-Ming Duan
ORCID
Author(s) ORCID Number
Yun-Ming Duan http://orcid.org/0009-0002-3464-0797
Funding Agency and Grant Number
Corresponding Author Yun-Ming Duan, School of Nursing, Shandong First Medical University and Shandong Academy of Medical Sciences, No. 619 Changcheng Road, Tai’an 271000, Shandong Province, China. dymin2019@163.com
Key Words Gastric cancer; Neoadjuvant chemotherapy; Pathological complete response; Predictive factor
Core Tip This study included patients with pathologically confirmed gastric adenocarcinoma who received neoadjuvant chemotherapy and completed radical gastrectomy + D2 dissection. Unified tumor regression grade assessment defines pathological complete response as the absence of residual primary tumor and lymph node metastasis. The system collected demographic data, comorbidities, tumor location and clinical stage, Lauren classification, human epidermal growth factor receptor 2/microsatellite instability/programmed death-ligand 1, baseline and dynamic laboratory indicators imaging and endoscopic responses, chemotherapy regimens/cycles/dose intensities and adverse reactions. With pathological complete responseas the primary outcome, univariate and multivariate logistic regression were used to screen independent predictors.
Publish Date 2025-10-24 07:36
Citation

Bi B, Liu C, Chai J, Duan YM. Retrospective analysis of predictive factors for pathological complete response after neoadjuvant chemotherapy in gastric cancer. World J Gastrointest Surg 2025; 17(10): 109700

URL https://www.wjgnet.com/1948-9366/full/v17/i10/109700.htm
DOI https://dx.doi.org/10.4240/wjgs.v17.i10.109700
Full Article (PDF) WJGS-17-109700-with-cover.pdf